Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B XNAS: LGND

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B Live Share Price Today, Share Analysis and Chart

Name: Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B: Is Infosys Ltd. worth buying?
Item: Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
Rating: 1.782555625
Author: Trendlyne DVM scores

Expensive Performer

Download real time

104.62 -2.18 (-2.04%)

54.49% Gain from 52W Low

74,819 XNAS Volume

XNAS 16 Apr, 2025 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Expensive Valuation

15.7 / 100

Technically Neutral

49.2 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

144

1Yr Price target upside is 37%

7 analysts

Ligand Pharmaceuticals, In... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B FAQ

How is Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B today?

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B today is trading in the red, and is down by -2.04% at 104.62.

How has Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B performed historically?

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B is currently trading down -2.04% on an intraday basis. In the past week the stock rose 8.22%. stock has been down -5.13% in the past quarter and rose 31.15% in the past year. You can view this in the overview section.